Role of anorectal myectomy after failed endorectal pull-through in Hirschsprung's disease

S Abbas Banani1, H Forootan

  • 1Department of Pediatric Surgery, Nemazee Hospital, Shiraz University of Medical Sciences, Iran.

Insights

Anorectal myectomy (ARM) effectively treats persistent symptoms after endorectal pull-through (ERPT) for Hirschsprung

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Colorectal Surgery

Background:

  • Hirschsprung's disease (HD) is a congenital condition affecting the large intestine.
  • Endorectal pull-through (ERPT) is a common surgical treatment for HD.
  • Some patients experience persistent symptoms post-ERPT, necessitating further intervention.

Purpose of the Study:

  • To evaluate the efficacy of Anorectal Myectomy (ARM) in patients with Hirschsprung's disease who have residual symptoms after ERPT.
  • To determine if ARM can alleviate persistent high anal canal pressure and associated symptoms.

Main Methods:

  • Retrospective analysis of 37 patients who underwent ERPT for HD.
  • Six patients with persistent symptoms (constipation, distension, enterocolitis) unresponsive to conservative therapy were identified.
  • Anorectal manometry was performed, revealing high anal canal pressure in these patients.
  • ARM, including posterior rectal myectomy and partial internal sphincterotomy, was performed 6-55 months post-ERPT.

Main Results:

  • Five of the six patients experienced marked improvement in symptoms after ARM.
  • One patient showed a partial response to ARM.
  • All six patients demonstrated a significant reduction in anal canal pressure post-ARM.
  • No patients required a secondary pull-through operation.

Conclusions:

  • Anorectal myectomy is a recommended and effective surgical option for managing persistent symptoms and high anal canal pressure following ERPT in Hirschsprung's disease patients.
  • ARM should be considered before pursuing more extensive secondary pull-through procedures.
  • Early intervention with ARM can improve outcomes and quality of life for select HD patients.